Recent evidence supports a role for T lymphocytes in allergic airway responses. We hypothesized that reducing blood T suppressor cells (Ts) might increase the late airway response (LR). Sprague-Dawley (SD) rats were sensitized with ovalbumin (OA). On days 8, 10, and 12, postsensitization test SD (n = 14) received monoclonal antibody intravenously (OX-8; 1 mg) specific to rat Ts. Controls received saline (n = 7) or mouse ascites IgG (n = 7). On day 14, animals were challenged with OA aerosol (5% wt/vol) for 5 min, lung resistance was recorded for 8 h (n = 18) and bronchoalveolar lavage was performed. The LR was determined from the area under the lung resistance vs time curve from 75 to 480 min after challenge. In the remaining 10 rats, airway lymphocyte subsets were measured 8 h after OA aerosol challenge in minced and digested lungs. A decrease in percentage of blood and airway Ts, respectively, in test animals was observed vs controls (blood: 6.27±0.84 vs 32.95±1.94, P < 0.001); (airway: 5.05±0.66 vs 24.5±3.05, P < 0.02). Blood and airway helper T lymphocytes did not differ between test and control animals. The LR was significantly increased in test (22.89±3.92) vs controls (4.22±2.18, P <0.001). Bronchoalveolar lavage macrophages, neutrophils and lymphocytes, and serum OA-specific IgE were also significantly elevated (P < 0.05) in test animals. We conclude that Ts play an important role in attenuating the LR in SD rats. (J.
Introduction
Recent evidence supports a role for the T lymphocyte in allergic airway responses (1) (2) (3) (4) . Although the evidence is circumstantial, there is ample reason to suggest that the T lymphocyte may be central to the airway inflammation that comes after allergen challenge. T lymphocyte-derived lymphokines play an important role in the regulation of IgE production and in mast cell and eosinophil differentiation and function (5) (6) (7) (8) (9) (10) . In particular, T lymphocyte suppressor cell dysfunction may have a pathogenetic role in atopic disease states. A relative defi-ciency of suppressor T lymphocytes has been reported in patients with allergic rhinitis (11, 12) , atopic dermatitis (13) , and both allergic (14) and nonallergic asthma (15, 16) . A decrease in T lymphocyte suppressor cell numbers and in mitogen induced suppressor cell activity has been described in asthma (17) (18) (19) (20) (21) (22) . A decrease in peripheral blood suppressor cells has been shown in chronic asthmatics who were refractory to corticosteroid therapy (23) .
We hypothesized that suppressor cells are involved in the late airway response that comes after antigen challenge, and that selective depletion of T suppressor cells using monoclonal antibodies would increase the late airway response to antigen challenge. To test this hypothesis, we used the mouse anti-rat monoclonal antibody OX-8, which is specific for suppressor/ cytotoxic T lymphocytes and natural killer cells (24, 25) . We studied the effect of previous administration of this antibody on antigen induced immediate and late bronchoconstriction in sensitized Sprague-Dawley rats. These rats developed homocytotropic IgE after sensitization, but late airway responses were uncommon (26 At the start of the experiment, rats ranged in age from 8 to 10 wk and weighed from 270 to 430 g. 28 animals were actively sensitized with a subcutaneous injection of I mg (0.8 ml) of chicken egg ovalbumin (OA)' (grade V; Sigma Immunochemicals, St. Louis, MO) precipitated in 3.48 mg of aluminum hydroxide gel in normal saline (0.2 ml). On the same occasion, 0.5 ml of Bordetella pertussis vaccine containing 1 X 1010 heat-killed bacilli was injected intraperitoneally as an adjuvant.
Study protocol. On days 8, 10, and 12 after sensitization, animals received an intravenous injection of either 1 mg of a mouse monoclonal antibody specific to rat suppressorT lymphocytes (OX-8; n = 14) or 1 mg ofascites from pristaned BALB/c mice injected intraperitoneally with SP2/0 myeloma cells (protein concentration 82.7±1.1 mg/ml) (n = 7) or saline (1 ml; n = 7). On day 14, blood was obtained forOA-specific IgE and lymphocyte subset measurements. Antigen challenge was performed and pulmonary resistance (RL) measurements were obtained in OX-8-treated (n = 8), ascites-treated (n = 3), and salinetreated (n = 7) rats for 8 h, and then bronchoalveolar lavage (BAL) was performed. In the remaining 10 rats (six administered OX-8 and four controls), 8 h after OA aerosol challenge, the lungs were minced and digested for the measurement ofinflammatory cell infiltration (27) . To evaluate the possibility that OX-8 mAb pretreatment, per se, might induce lung inflammation, another group of rats underwent sham sensitization with saline and then received 1 mg OX-8 mAb i.v. on days 8, 10, and 12 after sham sensitization. On day 14, anesthetized, intubated rats underwent BAL and were compared to saline-injected controls (n = 5).
Measurement ofpulmonary mechanics. Measurement ofairway response was performed as previously described (28) in animals that were anesthetized with urethane (1.1 g/kg) and orotracheally intubated. RL was determined by fitting the equation ofmotion ofthe lung to the data by multiple linear regression analysis using a commercial software package (RHT Infodat Inc., Montreal, Quebec).
Measurement ofairway responses to ovalbumin. On day 14 after sensitization, rats were anesthetized, intubated, placed on a heating pad, and rectal temperature was continuously monitored with an electronic thermometer (Telethermometer; Yellow Springs Instrument Co., Yellow Springs, OH). Animals were kept in the lateral decubitus position and alternated between left and right sides hourly. RL was measured at baseline, after a 5-min saline aerosol administration, immediately after the administration ofaerosols ofovalbumin, 5, 10, and 15 min after the ovalbumin and subsequently at 15-min intervals for a total period of 8 h. Aerosols of ovalbumin (5% wt/vol) were administered for 5 min using a Hudson nebulizer driven by a compressed air source of 10 liters/min resulting in a nebulizer output of0.16 ml/min.
Lung mincing and digestion. Lung mincing and digestion was performed as previously described (27) . Briefly, under general anesthesia, the chest wall was opened and the animal was exsanguinated by puncture ofthe left ventricle. The pulmonary vasculature was flushed with a balanced salt solution (10 ml) injected into the right ventricle until the effluent from the lungs was white. The lungs were separated into the large airways (trachea and large bronchi until the fifth generation, approximately), and small airways and parenchyma, washed in balanced salt solution, cut into 1-mm sections, and incubated separately for tissue digestion. Tissue digestion was performed by three 20-min incubations in 20 ml of enriched RPMI 1640 medium (RPMI 1640 supplemented with 100 U/ml of penicillin, 100 gg/ml of streptomycin, 10% heat inactivated fetal calf serum, 2 mmol/liter L-glutamine, and 0.1 mmol/liter nonessential amino acids) containing 20 U/ml collagenase. After each incubation, cells were separated from tissue by filtration through a sieve (model 60; Sigma Immunochemicals) and washed three times in RPMI. At the end of all three incubations, the cells were pooled and counted on a hemocytometer. Slides were prepared by centrifuging 500,000 cells in enriched RPMI 1640 for 5 min at 700 rpm in a cytocentrifuge (Cytospin-3; Shandon, Cheshire, United Kingdom). Cellular Lung lavage. BAL was performed in OX-8-(n = 6) treated animals, and in ascites IgG-(n = 3) and saline-(n = 4) treated controls. The lungs were lavaged through the endotracheal tube by instillation of5 ml of saline at room temperature followed by gentle aspiration and repeated five times. The volume retrieved averaged 83% ofthe 25 ml that were instilled. The total cell count was determined on a fresh specimen of fluid using a haemocytometer. Slides were prepared for differential cell count by centrifuging for 1 min at 2,000 rpm in a cytocentrifuge (Cytospin-2; Shandon). Cellular differential was assessed on a Wright Giemsa stain; 200 cells were counted under oil immersion microscopy.
IgE determination. Specific IgE levels to OA were determined by ELISA as previously described (29 tance at each time point after saline or OA challenge. In OX-8-treated animals, RL was significantly elevated during the late airway response (ANOVA, P < 0.0001). An early airway response to OA challenge was observed in two out ofeight OX-8-treated animals, compared to 2 out of 10 controls. Overall, the mean maximum percent ofbaseline RL during the 60 min after OA challenge was not significantly different from controls, but the late airway response as measured by the area under the RL vs time curve was significantly elevated in OX-8-treated animals compared to controls, P < 0.001 (Fig. 2) .
Blood lymphocyte subsets. The percent of blood lymphocyte helper and suppressor cells observed before OA challenge is shown in Fig. 3 Airway lymphocyte subsets. The percent ofairway lymphocyte helper and suppressor cells observed 8 h after OA aerosol challenge is shown in Fig. 4 Fig. 5 . The numbers of total leukocytes, macrophages, polymorphonuclear neutrophils, and lymphocytes were significantly elevated in BAL ofanimals treated with OX-8 compared to controls. The numbers of eosinophils found in BAL were small in both OX-8-treated animals (3.67±2.15 X 103) and in controls (2.00± 1.29 X 103), and were not significantly different. In animals that were not allergen sensitized or challenged, there was no significant difference in the total leukocytes and differential counts in the BAL after administration of OX-8 mAb compared to saline treated controls ( Table I ), indicating that OX-8 treatment, per se, did not induce lung inflammation.
OA-specific IgE. Ovalbumin specific IgE was detected in six of eight OX-8-treated animals (0.33±0.09 absorbance units) but in only 1 of 10 controls (0.01±0.01; P < 0.02).
Discussion
The current study provides evidence for an important role for CD8' T-lymphocytes in the regulation of the late airway response in the Sprague-Dawley rat. Previous depletion of circulating and airway CD8' T lymphocytes with a monoclonal antibody significantly increased the magnitude of the late airway response to inhaled allergen. This was accompanied by a significant increase in antigen-specific IgE and airway inflammation characterized by an influx of total leukocytes, macrophages, neutrophils, and lymphocytes into the airway lumen. The early airway response was not affected by CD8' depletion.
The OX-8+ phenotype is expressed on rat cytotoxic T cells and noncytotoxic T suppressor cells (Ts) (24) , as well as on a subset of natural killer cells (25) nal antibodies have demonstrated a suppressive role for CD8' cells (31, 32) . In BB/Wor rats, a model of spontaneous diabetes mellitus, OX-8 depletion prevented lymphocytic destruction of pancreatic beta cells (33) . CD4' cells can also exert suppressive activity (34, 35) . In our study, peripheral CD8' cells were significantly depleted while CD4' cells were not, suggesting that the former might be the final effector suppressive cells that play an important role in modulating the late airway reaction. The phenomenon of immune response suppression by T cells is well recognized. Downregulation of immune responses is believed to be determined by the joint activities of CD4' inducer T cells and CD8' T cells, including cytotoxic cells and Ts. A distinct Ts lineage likely exists (36) , but there is no universal agreement on this point (37) .
The sequence of events involved in immunosuppression is not entirely clear, but it has been postulated that Ts cells release suppressive factors that bind to antigen-presenting cells and other cells in secondary lymphoid tissue, and that these cells suppress effector cells such as T or B lymphocytes that arrive in that tissue (38, 39) . Inhibition ofTs using monoclonal antibodies could interfere with such mechanisms. In vitro data using the mixed leukocyte reaction model suggest that Ts inhibit an early event during the activation of CD4' cells (40) .
In our study, there was an increase in antigen-specific IgE in OX-8-depleted animals. Presumably the increase in IgE reflects the removal of suppressor effects on activated CD4' cells and a consequent promotion ofB cell synthesis ofIgE. The first dose ofOX-8 monoclonal antibody was administered 8 d after antigen sensitization. It is possible that administration of antibodies before sensitization might result in even greater promotion of antigen specific IgE. In the rat, the late airway response is dependent on the presence ofIgE (29) and correlates with the degree of T cell activation (41) . Thus, the late airway response may have been increased in the rat after peripheral CD8' depletion through enhancement of IgE production or by disinhibition of CD4+-activated cells. In humans, an increase in activated CD4' cells has been observed infiltrating allergen-injected skin sites during the late phase cutaneous reaction (42), and in the blood and bronchial biopsies in both stable and acute asthma (3, 4, 43, 44) .
We demonstrated a marked decrease in the percent ofOX-8+ cells in the blood and lungs in the rat after in vivo depletion. This finding could have reflected a reduction in the expression of OX-8 on the cell surface rather than suppressor cell depletion. However, depletion of CD8' cells in rats and mice has been shown to inhibit suppressor cell function (45, 33) . The findings of increased IgE, increased late airway bronchoconstriction, and increased cellular return from lung lavage strongly suggest that the function ofsuppressor cells was altered in the rats that received the monoclonal antibody. Furthermore, the administration ofthe OX-8 mAb itselfdid not affect the inflammatory cell population of the lung before allergen challenge, and therefore must have modified allergen responses through the modulation ofmechanisms triggered by challenge.
Other studies have examined the relationship between lymphocyte subsets in the blood or the lung and the late airway response. Dual and late asthmatic reactions caused by toluene diisocyanate exposure in humans are associated with an increase in percent blood CD8+ and a decrease in the blood CD4+/CD8+ ratio at 8 and 48 h after exposure (46 
